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The Cell Ontology
 An ontology of cell types built by biologists for the needs of data 
annotation and analysis.
 The main branch organizes and enumerates in vivo cell types.
 The Cell Ontology covers cell types from all of biology.
 The Cell Ontology is not
 A list of specific cell lines, immortal or otherwise, although the Cell 
Ontology may be used to describe such cells if they correspond to an 
in vivo cell type.
 A list of in vitro methods for preparing cell cultures, although the Cell 
Ontology may be used to describe the resulting cells if they 
correspond to an in vivo cell type.
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The Cell Ontology
 Initially developed in 2003 by Jonathan Bard, David States, 
Michael Ashburner, and Seung Rhee.
 First described in 2005, Genome Biology, 6:R21.
 Current version relies solely on is_a and develops_from 
relationships, with extensive multiple inheritance.
 Available as the file cell.obo at http://obofoundry.org and 
http://bioportal.bioontology.org/.
 Lindsay Cowell is the Cell Ontology liaison to the OBO Foundry 
to review the ontology for conformity to the OBO Foundry 
principles.
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Use Cases for
the Cell Ontology
 Data Annotation (ongoing for GO, future use for IEDB, IDO, and 
VO).
 Cross product term formation with GO, MP, and other ontologies 
(ongoing).
 Representation of flow cytometry results.
 Immune system modeling.
 Nervous system modeling.
 Others?
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NIAID Cell Ontology Workshop 
May 2008
 Gathering of NIAID experts on immune system 
cells with an interest in ontology.
 Two day meeting focusing on:
 Ontology best practices
 T cells
 B cells
 Dendritic cells
 Macrophages
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NIAID Cell Ontology Workshop 
May 2008
 Many additional cell types needed to represent 
immune cell types more fully.
 Need to restructure ontology to remove multiple 
inheritance.
 Desire to rebuild ontology via logical definitions for 
terms based on cross-products.
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Additional cell types added to 
represent immune cell types
Missing cell types:
 Th17 cell
 Tr1 cell
 Plasmablast
 inflammatory macrophage
 etc.
Precisely specified cell types :
 CD4-negative, CD8-negative type I NK T cell secreting IL-4
 mature CD8alpha-positive, CD11b-negative dendritic cell
 IgA Memory B Cell
 etc.
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Removal of multiple 
inheritance
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Removal of multiple 
inheritance
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Removal of multiple 
inheritance
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How do we describe cells?
 Morphology
 Surface markers
 Transcription factors
 Location
 Role or process involvement
 Lineage
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 Morphology
 Surface markers
 Transcription factors
 Location
 Role or process involvement
 Lineage
How do we describe cells?
Protein 
Ontology
Anatomy Ontology 
(FMA) GO 
Biological 
Process
Link to external ontology
Cell Ontology
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 Morphology
 Surface markers
 Transcription factors
 Location
 Role or process involvement
 Lineage
How do we describe cells?
has_part
located_in
participates
_in
Link via specific relationships
develops_from/has_lineage
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Rebuild ontology via logical 
definitions based on cross-products
name: CD4-positive, CD25-positive, 
alpha-beta regulatory T cell
def: "A CD4-positive, CD25-positive, 
alpha-beta T cell that regulates 
overall immune responses as well 
as the responses of other T cell 
subsets through direct cell-cell 
contact and cytokine release.”
name: induced T-regulatory cell
def: "CD4-positive alpha-beta T cell 
with the phenotype CD25-positive, 
CTLA-4-positive, and FoxP3-
positive with regulatory function."
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Rebuild ontology via logical 
definitions based on cross-products
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Rebuild ontology via logical 
definitions based on cross-products
id: CL:0000902
name: induced T-regulatory cell
def: "CD4-positive alpha-beta T cell with the phenotype CD25-
positive, CTLA-4-positive, and FoxP3-positive with regulatory 
function."
intersection_of: CL:0000792 ! CD4-positive, CD25-positive, 
alpha-beta regulatory T cell
intersection_of: has_part PRO:000001380 ! CD25
intersection_of: has_part PRO:000001852 ! CTLA-4
intersection_of: has_part PRO:000001350 ! FoxP3
intersection_of: participates_in GO:0050776 ! regulation of 
immune response
relationship: develops_from CL:0000896 ! activated CD4-
positive, alpha-beta T cell 
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A two step process:
CL 1.5 and CL 2.0
 “CL 1.5” is an intermediate step incorporating the 
results of the NIAID workshop on immune cell types 
within a modified CL and continuing to use only is_a 
and develops_from relationships.
 The term definitions in CL 1.5 contain most of the 
information required to build logical definitions.
 In CL 1.5 multiple inheritance for the immune cell 
types has largely been removed.
 The CL 1.5 improvements to the hematopoietic cells 
are implemented in the publicly available cell.obo file.
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A two step process:
CL 1.5 and CL 2.0
 “CL 2.0” represents the Cell Ontology rebuilt with 
logical definitions based cross-products with external 
ontologies.  We are currently seeking dedicated 
funding for this work.
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B cells
 Working Group:  Martin Zand, Richard Scheuermann
 Approximately 50 new cell types.
 Better coverage of
 precursor B cells
 immature B cells
 germinal center T cells
 memory B cells
 effector B cells
 plasma cells
 Focused on definition by cell surface marker expression and 
transcription factor expression, with some cells also described by 
participation in particular processes.
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T cells and NK cells
 Working Group:  Penelope Morel, Alexander Diehl
 Approximately 50 new cell types.
 Better coverage of
 Memory T cells
 Regulatory T cells
 Effector T cells
 NK T cells
 NK cells
 Focused on definition by cell surface marker expression and 
transcription factor expression, with some cells also described by 
participation in particular processes.
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Monocytes and Macrophages
 Working Group:  Elizabeth Gold and Anastasia Nijnik
 Approximately 30 new cell types.
 Better coverage of
 tissue macrophages
 activated macrophages
 Focused on definition by anatomical location with certain types 
having additional cell expression details.
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Dendritic cells
 Working Group:  Anna Maria Masci, Lindsay Cowell 
 Approximately 30 new cell types.
 Better coverage of
 conventional dendritic cells
 plasmacytotoid dendritic cells
 species-specific dendritic cell subtypes
 Focused on definition by cell surface marker expression.
 Paradigm for CL2.0 – DC-CL.N
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DC-CL
Dendritic cells
[Term]
id: DC_CL:0000010
name: immature CD8_alpha-negative CD11b-positive dendritic cell
def: "immature CD8_alpha-negative CD11b-positive dendritic cell is_a 
CD8_alpha-negative CD11b-positive dendritic cell that 
has_low_plasma_membrane_amount CD80, CD86, and MHCII." [AMM:amm]
comment: Current Opinion In Immunology 2008 20: 61-67
intersection_of: DC_CL:0000012 ! CD8_alpha-negative CD11b-positive 
dendritic cell
intersection_of: has_low_plasma_membrane_amount DC_CL:0000094 ! CD80
intersection_of: has_low_plasma_membrane_amount DC_CL:0000096 ! CD86
intersection_of: has_low_plasma_membrane_amount DC_CL:0000103 ! MHCII
relationship: develops_from DC_CL:0000041 ! common dendritic precursor
relationship: has_function DC_CL:0000135 ! antigen processing activity
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DC-CL
Dendritic cells
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Issues
 Some multiple inheritance remains for certain immune cell types 
in CL 1.5.
 Not all cell types can be easily defined by surface marker 
phenotype.
 The four subontologies represent four different styles to revise
the particular cell types in question.
 Some new cell types are highly specified and species-specific.  
Data annotators, however, also need general cell types.
 Example:  plasmacytoid dendritic cellN
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Conclusions & Future Work
 The CL 1.5 improvements to the hematopoietic cells are available
in the public cell.obo file.
 The full logical definition/cross-product approach will be applied 
to all hematopoietic cells:  “Hemo-CL”, and eventually the entire 
Cell Ontology for all cell types.
 The workshop approach with domain experts worked well for this 
revision.
 Cell definition is complicated by species differences as well as
developmental and activation states.Na
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